// STATE LEGISLATION TRACKER

Arizona SB 1458 — pharmacy board; civil penalties

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: Unknown

State: Arizona
Bill: SB 1458
Filed: 2026-01-29
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Arizona SB1458 appears to deal with the Arizona Board of Pharmacy and civil penalties. Based only on the title and subjects available, it does not directly target peptides, compounding, telehealth, prescribing scope, controlled substances, or prescription monitoring.

Key Points

No clear peptide-specific rule is visible from the title or subjects.
May matter indirectly to pharmacies if civil penalty authority changes.
No visible change to off-label prescribing or telehealth access.
No visible change to NP or naturopathic scope of practice.
No visible 503A, 503B, or FDA compounding language provided.

What to Watch For

Note Watch for bill text to confirm whether civil penalties apply to compounding pharmacies.

Concern Higher pharmacy penalties could raise compliance costs if applied to compounders.

Note No available signal that the bill changes peptide prescribing or patient access directly.

Where the Bill Stands

The provided source says the latest action refetch failed, and no reliable current status was available from the supplied information.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws